Tempus AI (NASDAQ:TEM) Trading Up 7.6% – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s stock price was up 7.6% during trading on Friday . The stock traded as high as $56.48 and last traded at $56.47. Approximately 355,200 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 1,195,705 shares. The stock had previously closed at $52.48.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on TEM shares. Needham & Company LLC reissued a “buy” rating and set a $47.00 price target on shares of Tempus AI in a report on Wednesday, August 7th. Piper Sandler reissued a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. JPMorgan Chase & Co. raised their target price on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Loop Capital boosted their price objective on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Finally, Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and upped their price target for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Tempus AI has a consensus rating of “Moderate Buy” and a consensus price target of $54.22.

Tempus AI Stock Performance

The stock has a 50-day moving average of $51.80. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI in the third quarter valued at approximately $30,000. Sandia Investment Management LP acquired a new position in shares of Tempus AI during the second quarter worth about $136,000. Vestor Capital LLC acquired a new stake in Tempus AI in the third quarter valued at about $153,000. Stifel Financial Corp purchased a new stake in Tempus AI in the 3rd quarter valued at approximately $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $258,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.